How large is the anthelmintic drugs market, and what is its growth trajectory?
The anthelmintic drugs market size has grown strongly in recent years. It will grow from $3.16 $ billion in 2024 to $3.34 $ billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the high prevalence of helminth infections, increasing public health initiatives, rise in pharmaceutical research and development, increasing awareness and education, and economic growth.
The anthelmintic drugs market size is expected to see strong growth in the next few years. It will grow to $4.11 $ billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing cases of parasitic infections globally, growing use of anthelmintics in livestock and pets, increasing awareness and health initiatives, and increased international travel. Major trends in the forecast period include rising demand for combination therapies, increasing focus on drug resistance management, growing adoption of personalized medicine, expansion of telemedicine in treatment monitoring, increasing research on novel drug targets, and emphasis on preventive healthcare measures.
Get Your Free Sample of The Global Anthelmintic Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19291&type=smp
What are the key forces behind the anthelmintic drugs market’s growth in recent years?
The high prevalence of parasitic infections is expected to propel the growth of the anthelmintic drugs market going forward. Parasitic infections are diseases caused by organisms that live on or inside another host, such as parasites such as protozoa, worms, or ectoparasites. Parasitic infections are fueled by poor sanitation, contaminated food or water, close contact with infected individuals or animals, inadequate hygiene, and a lack of access to clean resources. Anthelmintic drugs are used to treat infections caused by parasitic worms, effectively targeting and eliminating these parasites from the host’s body. These medications work by disrupting the parasites’ physiological functions, leading to their expulsion or death. For instance, in July 2023, according to the data published by the Centers for Disease Control and Prevention, a US-based national public health agency, the number of cyclosporiasis cases in Florida, caused by a microscopic parasite, increased twofold, rising from 254 in 2021 to 513 in 2022. Therefore, the high prevalence of parasitic infections is driving the growth of the anthelmintic drugs market.
What are the major segments of the anthelmintic drugs market?
The anthelmintic drugsmarket covered in this report is segmented –
1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes
2) By Route Of Administration: Oral, Injectable
3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections
4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores
5) By Application: Human Anthelmintics, Veterinary Anthelmintics
Subsegments:
1) By Benzimidazoles: Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole
2) By Macrocyclic Lactones: Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime
3) By Pyrazinoisoquinolones: Praziquantel, Cysticide
4) By Tetrahydropyrimidines: Pyrantel Pamoate, Pyrantel Tartrate
5) By Other Drug Classes: Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report
Which companies dominate the anthelmintic drugs market?
Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals, Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company
What major trends will shape the anthelmintic drugs market during the forecast period?
Major companies operating in the anthelmintic drugs market are focusing on developing innovative combination drugs to provide comprehensive protection against multiple parasites. Combination anthelmintic drugs are formulations that combine two or more anthelmintic agents to enhance efficacy against parasitic infections in humans and animals. They work synergistically to broaden the spectrum of activity, delay the development of drug resistance, and overcome existing resistance profiles in parasites. For instance, in January 2022, Zoetis Inc., a US-based animal health company, received approval from the U.S. Food and Drug Administration for Simparica Trio, a new label indication, allowing it to prevent infections caused by Borrelia burgdorferi, responsible for Lyme disease in dogs. Simparica Trio combines three active ingredients – sarolaner, moxidectin, and pyrantel to provide comprehensive protection against fleas, ticks, heartworms, roundworms, and hookworms.
What are the key regional dynamics of the anthelmintic drugs market, and which region leads in market share?
North America was the largest region in the anthelmintic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Anthelmintic Drugs Market Report 2025 Offer?
The anthelmintic drugs market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Anthelmintic drugs are medications used to treat infections caused by parasitic worms, or helminths. These drugs work by either killing the worms directly or disrupting their ability to reproduce. They are commonly prescribed for conditions such as roundworm, tapeworm, and hookworm infections.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19291
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
